Nanologica AB (publ) (NICA.ST)

SEK 1.71

(-0.58%)

Market Cap (In SEK)

151.09 Million

Revenue (In SEK)

1.44 Million

Net Income (In SEK)

-75.15 Million

Avg. Volume

53.07 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.63-10.65
PE
-
EPS
-
Beta Value
0.388
ISIN
SE0005454873
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Andreas Bhagwani
Employee Count
-
Website
https://www.nanologica.com
Ipo Date
2015-10-30
Details
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.